BOOTHBAY FUND MANAGEMENT, LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 164 filers reported holding ADMA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$3,741,859
+0.0%
1,045,212
+3.1%
0.09%
+8.5%
Q2 2023$3,741,059
-8.4%
1,013,837
-17.9%
0.08%
-2.4%
Q1 2023$4,086,208
+0.2%
1,234,504
+17.4%
0.08%
-10.6%
Q4 2022$4,079,374
-79.3%
1,051,385
-87.1%
0.09%
-80.9%
Q3 2022$19,734,000
-3.8%
8,121,153
-21.6%
0.49%
-8.7%
Q2 2022$20,514,000
+7.7%
10,360,400
-0.5%
0.54%
+21.9%
Q1 2022$19,047,000
+63.1%
10,408,259
+25.6%
0.44%
+61.1%
Q4 2021$11,680,000
+230.1%
8,283,860
+164.6%
0.28%
+180.6%
Q3 2021$3,538,000
+872.0%
3,130,536
+1276.2%
0.10%
+716.7%
Q2 2021$364,000
+2.0%
227,469
+12.0%
0.01%
-7.7%
Q1 2021$357,000
+27.5%
203,084
+41.5%
0.01%
+30.0%
Q4 2020$280,000
+30.2%
143,535
+59.3%
0.01%
-23.1%
Q3 2020$215,000
-17.0%
90,082
+1.8%
0.01%
-27.8%
Q2 2020$259,000
-40.3%
88,500
-41.3%
0.02%
-50.0%
Q1 2020$434,000150,7430.04%
Other shareholders
ADMA BIOLOGICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$13,240,00011.29%
Stonepine Capital Management, LLC 7,661,690$25,360,1948.50%
Altium Capital Management LP 2,870,000$9,499,7005.27%
Caligan Partners LP 1,662,613$5,503,2493.84%
AWM Investment Company, Inc. 6,015,000$19,909,6502.69%
Perceptive Advisors 11,900,255$39,389,8441.16%
EAM Investors, LLC 1,035,752$3,428,3390.67%
OBERWEIS ASSET MANAGEMENT INC/ 1,169,500$3,871,0450.60%
Magnetar Financial LLC 7,074,722$23,417,3300.46%
Virtus ETF Advisers LLC 83,925$277,7920.15%
View complete list of ADMA BIOLOGICS INC shareholders